Armenia · Medical and donor conditions

A doctor reviews treatment consent paperwork with a couple in a clinical consultation room; laboratory microscopes are visible through glass.

Armenia surrogacy: medical and donor requirements

Editorial illustration only; it is not evidence of a real clinic, patient or approval.

The short answer: there are separate legal and clinical gates

As of 23 October 2026, Armenia regulates gamete donation and surrogacy through Law HO-474-N and Government Decisions Nos. 907-N and 214-N. The law sets eligibility and exclusions; the decisions detail donor examinations and treatment protocols.

Do not treat a donor’s clearance as approval of a surrogate, or a surrogate’s medical clearance as proof that the intended parent(s) qualify. At least three questions must be answered separately: (1) may the intended parent(s) use the chosen ART route, including surrogacy; (2) does the donor meet the legal and medical rules for the particular gamete; and (3) does the person carrying the pregnancy meet the separate surrogate criteria and have no applicable contraindication? A positive answer to one does not resolve the others.

The law also ties access to ART to medical-social indications determined by the authorised health authority. For surrogacy, Article 12 separately restricts access where the intended woman has no medical contraindication to carrying a pregnancy. That is an intended-parent eligibility issue, not a substitute for screening the surrogate herself.

Before paying for medical screening, separately check Article 12’s intended-parent eligibility rules. The surrogacy route is unavailable to an unmarried man who would not be the child’s biological parent, to a woman who has no medical contraindication to carrying the pregnancy herself, and to foreign nationals who are not ethnic Armenians when the surrogate is an Armenian citizen. If the intended parent(s) would not be the child’s biological parent(s), Article 12(1.2) requires an interagency commission permit and limits this route to the statutory categories: Armenian-citizen married couples or unmarried women, and qualifying ethnic-Armenian foreign married couples or unmarried women who are lawfully present in Armenia and provide the prescribed proof of Armenian ethnic origin. This is a separate legal gate, not a medical test; confirm the exact facts and current procedure with Armenian counsel.

Gamete donor eligibility: age, testing and a point that needs confirmation

RouteRule stated in the official textsPractical reading
Sperm donorOrdinarily 18–40; fertile semen; medical-genetic examination; no donor contraindication.Apply the detailed screening and quality rules in Decision 907-N.
Oocyte donorOrdinarily 18–35; regular menstrual function; medical-genetic examination; no donor contraindication.Ovarian retrieval limits also apply.
Known donorArticle 14(2) separately refers to adults from age 18 donating gametes or an embryo to relatives or to a person/couple needing ART, after genetic-medical examination and with no contraindication.The interaction between this statutory wording and the implementing age ceilings should be confirmed in writing; do not assume it automatically waives an upper age limit.

The legal test includes age, prescribed medical-genetic examination and absence of contraindications; it is not merely a clinic’s general view that a candidate is healthy. Decision 907-N sets donor-specific tests. Ask the clinic to identify which additional requirements come from law, the decision or its own protocol.

Sperm donors: examinations and frequency

Decision 907-N sets a specific monitoring schedule for sperm donors. In practical terms, ask the clinic to show the current donor file and dates, not merely confirm that “screening was done.” The listed requirements include:

  • Each donation: semen analysis and assessment of suitability. For preservation and later ART use, the decision gives benchmarks of at least 2.0 ml volume, at least 40 million sperm cells per millilitre, at least 60% active progressive motility, and no more than 20% abnormal forms.
  • Yearly: examination by a urologist and therapist, with other specialists if needed.
  • Once:blood group and Rh factor; examination by a psychotherapist and medical-genetic consultation, with karyotyping when indicated.
  • Every three months: semen microscopy and culture, plus tests for sexually transmitted infections, including HIV, hepatitis B, hepatitis C and syphilis.

These are legal-procedure requirements, not a guarantee of a successful pregnancy or a complete statement of every test a clinician may need. Results must be interpreted by the treating team, and an outdated result should not be treated as current simply because a donor was previously accepted.

Oocyte donors: examinations and retrieval limits

For an oocyte donor, Decision 907-N requires a different schedule:

  • Therapeutic examination once a year and a gynaecological examination before each attempt; additional specialists may be involved when necessary.
  • Blood group and Rh factor recorded once, and a complete blood count and coagulogram.
  • Vaginal smear microscopy and microbiological culture every three months.
  • Testing every three months for sexually transmitted infections, including HIV, hepatitis B, hepatitis C and syphilis.
  • Ovulation monitoring by ultrasound folliculometry.
  • A one-time psychotherapist examination and medical-genetic consultation; karyotyping is performed when indicated.

The number of egg retrievals from a donor’s ovarian follicles must not exceed five. The decision provides a narrow exception where the same family needs further retrievals, but even then the total may not exceed seven. Do not read that exception as a general licence to repeat stimulation or retrieval without limit. The clinic should document the basis for any same-family exception and explain the medical risks and consent process.

Surrogate eligibility: statutory conditions and exclusions

Article 15 of the Law sets a separate route for the woman who will carry the pregnancy. Under the ordinary route, she must be 20–38 years old, have at least one child, have given birth no more than three times previously and have had no more than one caesarean delivery. She must undergo the prescribed medical examination, with no medical contraindication identified.

The law separately addresses a woman who wishes to carry a pregnancy using an embryo provided by relatives: she must be at least 20, have previously given birth at least once, undergo medical-genetic examination and have no identified contraindication to acting as a surrogate. Because the text describes this as an additional route, do not assume that it silently disapplies every other statutory restriction. Ask Armenian counsel and the clinic to confirm in writing how the relative-embryo route applies to the particular facts.

  • A woman in a registered marriage may act as a surrogate only with her husband’s consent.
  • A woman cannot act as a surrogate if a medical contraindication established by the authorised health authority applies.
  • A woman who has already acted as a surrogate at least twice is excluded.
  • A surrogate cannot simultaneously be the oocyte donor.

After pregnancy begins, the surrogate must register for medical care early, no later than 12 weeks’ gestation, remain under a doctor’s supervision and follow medical recommendations. If she lives separately from the intended parent(s), she must inform them about the course of the pregnancy. These obligations do not replace informed consent to individual medical procedures.

Medical checks before treatment: use the correct treatment pathway

Government Decision 214-N prescribes examinations before assisted reproduction and assisted insemination. The exact set depends on the pathway and the person being examined; a clinic should not present one generic “fertility package” as the complete legal checklist for every case.

Before diagnostic work for infertility, the listed examinations for a woman include: blood tests for syphilis, HIV and hepatitis B/C if not completed in the preceding three months; abdominal ultrasound; FSH, LH, prolactin and TSH testing (TSH if not completed in the preceding three months); anti-Müllerian hormone testing if not completed in the preceding 12 months; folliculometry; and investigations such as hysterosalpingography, hysteroscopy or laparoscopy when indicated.

For a man,the list includes semen analysis and microscopic examination of a urogenital smear, a urologist/andrologist consultation if results are abnormal, and STI testing when indicated.

Before IVF, the decision adds, among other things, therapist and gynaecologist examinations; ultrasound of abdominal organs, breasts and thyroid; blood group/Rh if not already recorded; blood count and biochemistry including coagulation where the required recent result is not available; syphilis/HIV/hepatitis B/C testing; relevant smears; hormone tests; and testing for specified perinatal infections such as chlamydia, herpes, cytomegalovirus, toxoplasmosis and rubella. A therapist’s conclusion on the woman’s health and ability to carry a pregnancy is listed. For men, the IVF pathway includes infection screening, semen analysis/smear where needed and urologist/andrologist consultation. Some additional investigations are indication-based rather than universal.

Contraindications and prohibitions are pathway-specific

Decision 214-N lists contraindications to assisted insemination. For a woman, these include diagnosed physical or mental conditions in which pregnancy is contraindicated, uterine malformations incompatible with carrying a pregnancy, malignant neoplasms, sexually transmitted infections until treatment is complete or remission is reached, and acute inflammatory or infectious illness until treatment is complete. For a man, the listed contraindications include sexually transmitted infections until treatment is complete or remission is reached and acute infection until treatment and the acute phase have ended.

The decision separately lists IVF contraindications: physical or mental illnesses that prevent pregnancy and childbirth; congenital or acquired uterine-cavity defects that make embryo transfer or carrying a pregnancy impossible; benign uterine or adnexal tumours requiring surgical treatment until treatment is completed; acute inflammatory diseases at any site; and malignant neoplasms, subject to a specific exception for certain fertility-preservation cases.

Surrogacy-specific contraindications and required examinations

Surrogacy-specific contraindications and required examinations

Government Decision No. 214-N, Annex 2, paragraph 50, separately lists contraindications specific to surrogacy: physical or mental illnesses for which pregnancy and childbirth are contraindicated; congenital or acquired defects of the uterine cavity that make embryo transfer or carrying a pregnancy impossible; benign neoplasms of the uterus or adnexa that require treatment; acute inflammatory diseases at any location; and malignant neoplasms at any location.

Annex 2, paragraph 51, prescribes the mandatory examinations before surrogacy: examination by an internist and a gynaecologist; abdominal-organ ultrasound; blood group and Rh factor if not already recorded; a complete blood count including coagulation factors if not performed in the preceding month; blood tests for HIV, syphilis, hepatitis B and C if not performed in the preceding three months; testing for chlamydia, mycoplasma, herpes, cytomegalovirus, toxoplasmosis and rubella; microscopic examination of urethral and cervical-canal smears; an internist’s conclusion on health and ability to carry a pregnancy; human papillomavirus (HPV) PCR testing; and other tests where medically indicated.

The current ARLIS consolidation marks Decision No. 214-N as in force from 31 January 2025. Article 15(4)(1) also refers to contraindications established by the authorised health authority. Check with the health authority whether a separate current order supplements Decision No. 214-N. If a clinic relies on an additional order, request its number, date, current status and applicable item. Do not substitute the assisted-insemination or IVF lists for the surrogacy-specific list in paragraph 50.

Annex 2, paragraph 51, prescribes the mandatory examinations before surrogacy: examination by an internist and a gynaecologist; abdominal-organ ultrasound; blood group and Rh factor if not already recorded; a complete blood count including coagulation factors if not performed in the preceding month; blood tests for HIV, syphilis, hepatitis B and C if not performed in the preceding three months; testing for chlamydia, mycoplasma, herpes, cytomegalovirus, toxoplasmosis and rubella; microscopic examination of urethral and cervical-canal smears; an internist’s conclusion on health and ability to carry a pregnancy; human papillomavirus (HPV) PCR testing; and other tests where medically indicated.

The current ARLIS consolidation marks Decision No. 214-N as in force from 31 January 2025. Article 15(4)(1) also refers to contraindications established by the authorised health authority. Check with the health authority whether a separate current order supplements Decision No. 214-N. If a clinic relies on an additional order, request its number, date, current status and applicable item. Do not substitute the assisted-insemination or IVF lists for the surrogacy-specific list in paragraph 50.

The medical rules above govern eligibility for the programme. If you are considering an elective cosmetic procedure during pregnancy, discuss it with your pregnancy care clinician and check the terms of your agreement. For that conversation, see the guide to cosmetic procedures during pregnancy: what is usually allowed.

Sex selection through ART is prohibited unless there is a risk of inheriting a sex-linked disease or the family already has three children of the same sex. A clinic’s commercial offer cannot create an additional legal exception.

Donor material, records, consent and confidentiality

Under Decision 214-N, assisted insemination using semen from an unknown donor may use only frozen semen. Fresh semen may be used for a spouse or a known donor. This is a treatment rule, not merely a clinic preference.

Decision 907-N also limits the number of children born from each gamete donor: no more than seven children across five families under the wording of the decision. Active sperm donation may continue for no more than three years, with no more than three donations per month. Donor selection follows the prescribed examinations and requires the donor’s written consent.

The Law allows a gamete donor to receive monetary compensation under a contract concluded in advance and authenticated in the prescribed manner. A donor has no rights or duties toward a child born through the use of the donated gamete under Article 14(6). For a known donor, Article 13 requires a written agreement with the ART user(s), notarised in accordance with the law. Do not assume that a clinic’s general consent form replaces a contract required by law.

ART-related information is medical secret and is not generally open to publication; disclosure is limited to legally specified circumstances. The law also requires ART services to be provided by a healthcare organisation licensed for the relevant type of medical assistance. Ask to see the exact licence scope and the clinic’s current written protocol for donor selection, test validity, storage and traceability.

What is law, and what may be clinic policy?

The Law and government decisions set binding requirements. A clinic may add case-specific safeguards, and a physician may recommend tests above the legal minimum, but internal policy is not automatically Armenian law. Advertising a service does not prove that a particular participant qualifies.

Ask the clinic to separate its answer into three columns: (1) the exact statutory provision or government-decision paragraph; (2) the medical reason for any additional test or exclusion; and (3) the clinic’s internal policy, including whether it is mandatory, how long results remain valid and whether an exception can be reviewed. If the clinic relies on a Ministry of Health order for surrogate contraindications, request its number, date, current status and the relevant item. A vague reference to “Armenian rules” is not enough to verify a decisive exclusion.

Practical checklist before paying or signing

  1. Obtain the proposed ART pathway in writing: assisted insemination, IVF, donor gametes, donor embryo and/or transfer to a surrogate are not interchangeable routes.
  2. Request the legal basis for the intended parent(s)’ access to surrogacy, including the medical evidence required to show that the intended woman cannot carry the pregnancy, where relevant.
  3. Ask for the donor’s category (known or unknown), age basis, date-stamped screening results, genetic-medical assessment, and confirmation that donor and child/family limits have been checked.
  4. For an oocyte donor, confirm the number of previous retrievals and the legal basis for any same-family exception. For sperm, verify the required semen-quality results and infection-test dates.
  5. For the surrogate, verify age, prior live birth, number of previous deliveries, caesarean history, any previous surrogacy, marital consent where applicable, and the exact medical-contraindication list applied. Also check Government Decision No. 214-N, Annex 2, paragraphs 50–51, and ask whether any additional current health-authority order applies. Also check Government Decision No. 214-N, Annex 2, paragraphs 50–51, and ask whether any additional current health-authority order applies.
  6. Get the required written and notarised agreement(s), compensation terms, consent forms, storage/traceability arrangements and a copy of the clinic’s relevant licence before making an irreversible payment.
  7. Have an Armenian lawyer review the actual records and current rules, especially any claimed exception to an age limit or to the ordinary surrogate criteria.

Limits of this guide and the next decision

This article answers the medical and donor-rule question; it does not determine whether a specific foreign or Armenian intended parent is eligible, whether a contract is enforceable in a particular dispute, who will be recorded as a legal parent, or whether another country will recognise parentage or issue travel documents. Those are separate questions and must be checked under the relevant laws.

One remaining source check is whether a separate, current health-authority order supplements the surrogacy-specific contraindications and mandatory examinations in Decision No. 214-N, Annex 2, paragraphs 50–51. Those paragraphs do contain a surrogacy-specific contraindication list and required examinations. Article 15(4)(1) separately refers to contraindications established by the authorised health authority. If a clinic applies an additional order, obtain its exact number, date, current status and relevant item.

Official sources

  1. Law of the Republic of Armenia HO-474-N, current consolidated text (Armenian)
  2. Government Decision No. 907-N, current consolidated donor rules (Armenian)
  3. Government Decision No. 214-N, current consolidated assisted-reproduction rules (Armenian)

Last updated:

Author: Khachatrian Razmik, LL.M.

International surrogacy and parentage legal services — LEX SURROGACY by Lex Agency · Author profile · Editorial standards